- £103.92m
- £165.92m
- £241.40m
- 69
- 92
- 62
- 91
Annual income statement for Renold, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 189 | 165 | 195 | 247 | 241 |
| Cost of Revenue | |||||
| Gross Profit | 121 | 105 | 130 | 162 | 161 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 179 | 155 | 179 | 224 | 211 |
| Operating Profit | 10.1 | 10.7 | 16.2 | 22.9 | 30.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 4.9 | 6.1 | 12.4 | 17.3 | 22.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.4 | 4.6 | 10.2 | 11.8 | 17.1 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 1.8 | 4.6 | 10.2 | 11.8 | 17.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 1.8 | 4.6 | 10.2 | 11.8 | 17.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.026 | 0.007 | 0.045 | 0.06 | 0.076 |
| Dividends per Share |